Display options
Share it on

J Perinat Med. 2010;38(1):71-6. doi: 10.1515/jpm.2010.009.

Cholinergic signal activated renin angiotensin system associated with cardiovascular changes in the ovine fetus.

Journal of perinatal medicine

Chunsong Geng, Caiping Mao, Lei Wu, Yu Cheng, Rulu Liu, Bingxin Chen, Ling Chen, Lubo Zhang, Zhice Xu

Affiliations

  1. Perinatal Origin Diseases Research Institute, First Affiliated Hospital of Soochow University, Suzhou, China.

PMID: 19921993 PMCID: PMC3009554 DOI: 10.1515/jpm.2010.009

Abstract

AIM: Cholinergic regulation is important in the control of cardiovascular and endocrine responses. The mechanisms behind cardiovascular responses induced by cholinergic activation are explored by studying hormonal systems, including renin-angiotensin and vasopressin (VP).

RESULTS: In chronically prepared fetal sheep, intravenous infusion of the cholinergic agonist carbachol increased fetal systolic, diastolic, and mean arterial pressure accompanied with bradycardia at near-term. Although intravenous administration of carbachol had no effect on plasma VP concentrations, this agonist increased angiotensin I and angiotensin II levels in fetal plasma. Fetal blood values, including sodium, osmolality, nitric oxide, hemoglobin, and hematocrit were unchanged by intravenous carbachol.

CONCLUSION: Cholinergic activation by carbachol controls fetal blood pressure and heart rate in utero. An over-activated fetal renin-angiotensin-system (RAS) is associated with changes in vascular pressure following intravenous administration of carbachol, indicating that the cholinergic stimulation-mediated hormonal mechanism in the fetus might play a critical role in the regulation of cardiovascular homeostasis.

References

  1. Neuropharmacology. 1977 Jul-Aug;16(7-8):463-72 - PubMed
  2. Annu Rev Pharmacol Toxicol. 1982;22:341-81 - PubMed
  3. Brain Res. 1997 Feb 14;748(1-2):107-21 - PubMed
  4. Am J Physiol Regul Integr Comp Physiol. 2001 Jun;280(6):R1837-43 - PubMed
  5. Eur J Pharmacol. 1996 Aug 8;309(2):183-7 - PubMed
  6. Hypertension. 1989 Jun;13(6 Pt 1):549-57 - PubMed
  7. Brain Res Bull. 1995;37(5):463-6 - PubMed
  8. Proc Soc Exp Biol Med. 1976 Jan;151(1):101-4 - PubMed
  9. Neuropsychopharmacology. 2005 Dec;30(12):2162-8 - PubMed
  10. Pediatr Res. 2001 May;49(5):678-85 - PubMed
  11. Pediatr Res. 2004 Nov;56(5):756-62 - PubMed
  12. Circ Res. 1977 Apr;40(4):401-7 - PubMed
  13. Neuroscience. 1995 Nov;69(1):199-208 - PubMed
  14. Braz J Med Biol Res. 1997 Apr;30(4):493-6 - PubMed
  15. Brain Res. 1979 Apr 13;165(2):295-310 - PubMed
  16. Neuropharmacology. 1972 Sep;11(5):637-44 - PubMed
  17. Neuropharmacology. 1987 Dec;26(12):1701-6 - PubMed
  18. Neuropeptides. 1988 Nov-Dec;12(4):199-206 - PubMed
  19. J Dev Physiol. 1990 Jan;13(1):17-23 - PubMed
  20. Am J Physiol Regul Integr Comp Physiol. 2002 Mar;282(3):R837-41 - PubMed
  21. J Cardiovasc Pharmacol. 1996 Jun;27(6):891-900 - PubMed
  22. Environ Res. 1984 Dec;35(2):430-8 - PubMed
  23. Am J Physiol. 1975 Feb;228(2):337-44 - PubMed

Substances

MeSH terms

Publication Types

Grant support